ANIL VASUDEVAN,BRUCE CLAPHAM,CLARA I VILLAMIL,DAVID J CALDERWOOD,GAGANDEEP SOMAL,KELLY D MULLEN,MICHAEL FRIEDMAN,MICHAEL J MORYTKO,MICHAEL Z HOEMANN,NOEL S WILSON,PHILIP COX
申请号：
BR112013008240
公开号：
BR112013008240A2
申请日:
2011.10.07
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
The present invention is directed to novel compounds of Formula (I) pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates and hydrates thereof wherein the variables are defined as herein. The compounds of Formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.
